A Multi-Center, Open-Label Trial Investigating Behavior Related to Ella Use in a Simulated OTC Environment (LIBRella)
Phase of Trial: Phase III
Latest Information Update: 14 Aug 2018
Price : $35 *
At a glance
- Drugs Ulipristal (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms LIBRella
- Sponsors HRA Pharma
- 03 Aug 2018 Status changed from active, no longer recruiting to completed.
- 03 May 2018 Planned End Date changed from 1 Apr 2018 to 1 Jun 2018.
- 03 May 2018 Planned primary completion date changed from 1 Apr 2018 to 1 Jun 2018.